In Natus Proxy Fight Glass Lewis Supports Voce Nominees


BOSTON – Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management’s nominees.

Glass Lewis & Co’s recommendation, released to clients late on Tuesday and seen by Reuters on Wednesday, echoes last week’s report from Institutional Shareholder Services (ISS), which also suggests that shareholders oust the medical equipment and supplies company’s two directors who are up for election this year.

Both Glass Lewis and ISS wrote that the company’s financial performance has been weak and lagged its peers, making it appropriate to elect dissident directors Lisa Wipperman Heine and Joshua Levine. Natus’ annual meeting is scheduled for June 22.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

WhatsApp chat